51.69 USD
+1.03
2.03%
At close Updated Nov 11, 4:00 PM EST
Pre-market
After hours
52.01
+0.32
0.62%
1 day
2.03%
5 days
6.29%
1 month
5.92%
3 months
9.49%
6 months
1.23%
Year to date
7.26%
1 year
2.11%
5 years
0.14%
10 years
14.76%
 

About: Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Employees: 82,878

0
Funds holding %
of 7,512 funds
0
Analysts bullish %
of 1 analysts
0
Positive news %
of 23 articles
Price charts implemented using Lightweight Charts™